Vitamin D3 for Life

Live Enlightened

Article

Renal and Intestinal CYP24A1 Regulation: Study Summary

Previous related pageRenal and Intestinal CYP24A1 Regulation: Full Evidence ReviewNext related pageRoles of CYP27B1 and CYP24A1 in activation and inactivation: Full Study Summary
Study at a glance

How did researchers test vitamin D breakdown in different tissues?

Researchers studied mice in which CYP24A1, an enzyme involved in vitamin D breakdown, was removed throughout the body, in the kidneys or in the intestine. They checked that the enzyme had lost its function in the intended tissue. They then compared vitamin D activity during normal feeding, high-calcium feeding and experimentally caused kidney disease.

How did losing the vitamin D breakdown enzyme affect the kidneys and intestine?

Removing the kidney enzyme raised active vitamin D and its starting compound in the blood. It also caused mildly high blood calcium and lowered PTH, a hormone that helps regulate calcium. Removing the intestinal enzyme increased vitamin D-related gene activity within the intestine without causing the same blood pattern. Local activity therefore changed without a matching rise in circulating active vitamin D.

What changed during high-calcium feeding or kidney disease?

During high-calcium feeding, mice without the intestinal enzyme had lower PTH and more calcium in urine despite unchanged blood calcium and active vitamin D. The researchers interpreted this as evidence of greater calcium absorption. During experimentally caused kidney disease, intestinal enzyme loss lowered PTH and FGF23, another mineral-regulating hormone. Blood calcium and phosphate did not rise, but kidney injury itself was not reduced.

Do these vitamin D breakdown experiments establish a treatment?

FGF23 rose slightly during high-calcium feeding. During kidney disease, it was lower than in comparison mice with kidney disease. Its response was therefore not the same in every setting. These experiments show that an enzyme’s location can change its effects. They do not establish a treatment for people, a safe dose of a medicine that blocks the enzyme or long-term health benefits.

Read the full article below ↓

Fuchs and colleagues tested whether CYP24A1 performs the same physiological job in the kidney and intestine. Their mouse models show a clear difference. Renal CYP24A1 strongly influences circulating vitamin D metabolites and systemic mineral feedback. Intestinal CYP24A1 can regulate local vitamin D activity without producing the same circulating metabolite pattern.

The study therefore adds a tissue level explanation to Vitamin D Clearance and Degradation.

What question did the study test?

The central question was whether renal CYP24A1 mainly controls systemic vitamin D exposure while intestinal CYP24A1 can regulate local activity independently.

The distinction is important because How Cellular Vitamin D Metabolism Differs Between Tissues explains why the same metabolic machinery can have different consequences in different tissues.

How was CYP24A1 removed?

The researchers created mouse models in which Cyp24a1 could be deleted globally, in the nephron and kidney, or in intestinal epithelial cells. Control mice received the same experimental treatments without the relevant deletion.

The investigators verified where recombination occurred and also tested whether enzyme function had genuinely been lost. Renal cells lacking CYP24A1 failed to generate the expected 24,25D response after exposure to 25D.

The roles of the two major enzymes are explained in Vitamin D Enzyme Pathways (CYP27B1 / CYP24A1).

What happened when renal CYP24A1 was deleted?

Renal deletion produced a pattern resembling global deletion. Circulating 1,25D and 25D increased, 24,25D fell, PTH was suppressed and FGF23 increased. Mild hypercalcaemia was also present.

The result supports a major renal role in controlling systemic vitamin D exposure and complements the broader physiology in Vitamin D and Kidneys.

What happened when intestinal CYP24A1 was deleted?

Intestinal deletion produced a different effect. Vitamin D receptor responsive genes increased within the intestine, but the circulating vitamin D metabolite pattern did not reproduce the changes seen after renal or global deletion.

This provides experimental support for the distinction described in Vitamin D Metabolism at the Cellular Level. Local vitamin D activity can change even when circulating measurements remain comparatively stable.

The result also connects with Vitamin D and Intracrine Activity, where local production, action and degradation are considered separately from the circulating endocrine pool.

What did the calcium challenge show?

During a diet containing 2.0% calcium, global and renal knockout mice developed or worsened hypercalcaemia. Intestinal knockout mice did not reproduce this systemic pattern.

However, PTH was significantly lower in the intestinal knockout despite unchanged serum calcium and circulating 1,25D. Urinary calcium excretion increased. For a given serum calcium concentration, the urine calcium to creatinine ratio was 0.72 units higher than in controls, with a 95% confidence interval from 0.18 to 1.26 and P = 0.01.

The authors interpreted this as evidence of greater local intestinal calcium absorption. The wider physiological relationship is described in Vitamin D Calcium Physiology.

What did the chronic kidney disease experiment add?

In mice with adenine induced kidney disease, intestinal Cyp24a1 deletion reduced PTH and FGF23 compared with disease controls without increasing serum calcium or phosphate and without reducing the severity of kidney injury itself.

The FGF23 result requires qualification. FGF23 increased modestly during the calcium challenge but was lower during the chronic kidney disease experiment. The study therefore does not support one universal direction of FGF23 change. The broader relationship is described in Vitamin D and Phosphate Regulation.

What is the strongest conclusion?

The strongest conclusion is that CYP24A1 function depends on physiological location. Renal loss strongly affects the circulating vitamin D system. Intestinal loss can increase local signalling and alter calcium and PTH physiology without producing the same systemic metabolite response.

The experiment does not establish a human CYP24A1 treatment strategy, a safe inhibitor dose or long term clinical benefit. It is mechanistic mouse evidence.

Primary source and publication details

Fuchs MAA, Grabner A, Shi M, et al.

Intestinal Cyp24a1 regulates vitamin D locally independent of systemic regulation by renal Cyp24a1 in mice.

Journal of Clinical Investigation. 2025;135(4):e179882.

PMID: 39688907

PMCID: PMC11827884

DOI: 10.1172/JCI179882

View the verified primary source

Related reading

Original sources